Saturday 7 April 2012

Rare germline large rearrangements i... [Breast Cancer Res Treat. 2012] - PubMed - NCBI

how rare are rearrangements in cancer? 

http://www.ncbi.nlm.nih.gov/pubmed/22476849
Breast Cancer Res Treat. 2012 Apr 5. [Epub ahead of print]

Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition.

Source

Laboratoire d'Oncogénétique, Institut Curie-Hôpital René Huguenin, 35 rue Dailly, 92210, Saint-Cloud, France, etienne.rouleau@curie.net.

Abstract

Hereditary breast cancers account for up to 5-10 % of breast cancers and a majority are related to the BRCA1 and BRCA2 genes. However, many families with breast cancer predisposition do not carry any known mutations for BRCA1 and BRCA2 genes. We explored the incidence of rare large rearrangements in the coding, noncoding and flanking regions of BRCA1/2 and in eight other candidate genes-CHEK2, BARD1, ATM, RAD50, RAD51, BRIP1, RAP80 and PALB2. A dedicated zoom-in CGH-array was applied to screen for rearrangements in 472 unrelated French individuals from breast-ovarian cancer families that were being followed in eight French oncogenetic laboratories. No new rearrangement was found neither in the genomic regions of BRCA1/2 nor in candidate genes, except for the CHEK2 and BARD1 genes. Three heterozygous deletions were detected in the 5' and 3' flanking regions of BRCA1. One large deletion introducing a frameshift was identified in the CHEK2 gene in two families and one heterozygous deletion was detected within an intron of BARD1. The study demonstrates the usefulness of CGH-array in routine genetic analysis and, aside from the CHEK2 rearrangements, indicates there is a very low incidence of large rearrangements in BRCA1/2 and in the other eight candidate genes in families already explored for BRCA1/2 mutations. Finally, next-generation sequencing should bring new information about point mutations in intronic and flanking regions and also medium size rearrangements.

PMID:
 
22476849
 
[PubMed - as supplied by publisher]

No comments:

Post a Comment

Datanami, Woe be me